Letters Section Editor: Jody W. Zylke, MD, Senior Editor.
Author Affiliations: Intramural Research Program, National Institutes of Health, Bethesda, Maryland (firstname.lastname@example.org).
To the Editor: In the study by Dr Isanaka and colleagues,1 patients with human immunodeficiency virus (HIV) receiving highly active antiretroviral therapy were treated either with standard-dose or high-dose multivitamin supplements, with no difference in outcomes. The authors concluded that high-dose vitamin supplements have no benefit in these patients.
Padayatty SJ, Levine M. Standard-Dose vs High-Dose Multivitamin Supplements for HIV. JAMA. 2013;309(6):545–546. doi:10.1001/jama.2012.216991
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: